Anavex Life Company Leadership
AVXL Stock | USD 9.03 0.01 0.11% |
About 66 percent of all Anavex Life's insiders are acquiring. The analysis of the overall insider sentiment regarding Anavex Life Sciences suggests that many insiders are confidant. Anavex Life employs about 40 people. The company is managed by 14 executives with a total tenure of roughly 6 years, averaging almost 0.0 years of service per executive, having 2.86 employees per reported executive.
Stephan Toutain President Senior Vice President - Operations |
Anavex Life's Insider Buying Vs Selling
66
Selling | Buying |
Latest Trades
2024-06-14 | Peter D.O. Donhauser | Acquired 2835 @ 3.64 | View | ||
2024-05-15 | Steffen Thomas | Acquired 5000 @ 4.52 | View | ||
2024-03-28 | Christopher U Missling | Disposed 73380 @ 5.11 | View |
Monitoring Anavex Life's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Anavex |
Anavex Life's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Anavex Life's future performance. Based on our forecasts, it is anticipated that Anavex will maintain a workforce of about 40 employees by December 2024.Anavex Life Management Team Effectiveness
The company has return on total asset (ROA) of (0.2043) % which means that it has lost $0.2043 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3003) %, meaning that it created substantial loss on money invested by shareholders. Anavex Life's management efficiency ratios could be used to measure how well Anavex Life manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.29. Return On Capital Employed is expected to rise to -0.43 this year. At this time, Anavex Life's Total Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 186.4 M this year, although the value of Other Assets will most likely fall to about 3.7 M.Common Stock Shares Outstanding is expected to rise to about 96.3 M this year, although the value of Net Loss is projected to rise to (40.6 M).
Anavex Life Workforce Comparison
Anavex Life Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 5,134. Anavex Life maintains roughly 40.0 in number of employees contributing less than 1% to equities under Health Care industry.
Anavex Life Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Anavex Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Anavex Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Anavex Life insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 2.3333 | 7 | 3 | 333,380 | 271,760 |
2023-06-01 | 0.6667 | 2 | 3 | 500,000 | 768,000 |
2022-06-01 | 7.0 | 7 | 1 | 350,000 | 50,000 |
2021-06-01 | 0.8125 | 13 | 16 | 364,316 | 761,632 |
2021-03-01 | 1.3333 | 4 | 3 | 146,665 | 291,000 |
2018-03-01 | 4.0 | 4 | 1 | 5,960 | 50,000 |
2015-12-01 | 1.0 | 2 | 2 | 6,000 | 100,000 |
2015-06-01 | 12.0 | 12 | 1 | 658,000 | 200,000 |
2012-03-01 | 2.0 | 2 | 1 | 12,000 | 150,000 |
2010-06-01 | 4.0 | 4 | 1 | 200,000 | 700,000 |
2009-06-01 | 0.5 | 1 | 2 | 400,000 | 694,444 |
2008-06-01 | 3.0 | 3 | 1 | 700,000 | 150,000 |
2007-09-01 | 1.0 | 1 | 1 | 92,500 | 950,000 |
2007-03-01 | 3.0 | 3 | 1 | 500,000 | 0.00 |
2006-06-01 | 0.5 | 2 | 4 | 8,312,500 | 1,662,500 |
Anavex Life Notable Stakeholders
An Anavex Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Anavex Life often face trade-offs trying to please all of them. Anavex Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Anavex Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stephan Toutain | Senior Vice President - Operations | Profile | |
MS MBA | Senior COO | Profile | |
Clint Tomlinson | VP Corporate | Profile | |
CPA CPA | Principal Treasurer | Profile | |
David RPh | Senior Affairs | Profile | |
Juan MD | Senior Development | Profile | |
Dr RPh | VP Affairs | Profile | |
Kun Jin | Head Biostatistics | Profile | |
Terrie Kellmeyer | Senior Development | Profile | |
MD MPH | Chief Officer | Profile | |
Walter MD | Chief Officer | Profile | |
Adebayo Laniyonu | Senior Development | Profile | |
CGA CPA | Principal Treasurer | Profile | |
MBA MS | President, Chairman | Profile |
About Anavex Life Management Performance
The success or failure of an entity such as Anavex Life Sciences often depends on how effective the management is. Anavex Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Anavex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Anavex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.28) | (0.29) | |
Return On Capital Employed | (0.45) | (0.43) | |
Return On Assets | (0.28) | (0.29) | |
Return On Equity | (0.39) | (0.40) |
Anavex Life Workforce Analysis
Traditionally, organizations such as Anavex Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Anavex Life within its industry.Anavex Life Manpower Efficiency
Return on Anavex Life Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.2M | |
Net Loss Per Executive | 3.4M | |
Working Capital Per Employee | 3.5M | |
Working Capital Per Executive | 10.1M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.